Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma

Purpose Our aim was to examine the prognostic significance of ERbeta1 and ERbeta2 expression in ERalpha-negative breast carcinomas. Materials and methods We evaluated nuclear and cytoplasmic expression of ERbeta1 and ERbeta2 by immunohistochemistry in a group of 95 patients with long follow-up. ERbe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cancer research and clinical oncology 2013-09, Vol.139 (9), p.1489-1498
Hauptverfasser:	Chantzi, Νiki Ι., Tiniakos, Dina G., Palaiologou, Marina, Goutas, Nikolaos, Filippidis, Theodoros, Vassilaros, Stamatis D., Dhimolea, Eugen, Mitsiou, Dimitra J., Alexis, Μichael N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Biological and medical sciences Biomarkers, Tumor - metabolism Breast cancer Breast Neoplasms - metabolism Breast Neoplasms - mortality Breast Neoplasms - therapy Cancer Research Cell Nucleus - metabolism Cytoplasm - metabolism Estrogen Receptor alpha - metabolism Estrogen Receptor beta - metabolism Estrogens Female Follow-Up Studies Gynecology. Andrology. Obstetrics Hematology Humans Immunoenzyme Techniques Immunohistochemistry Internal Medicine Lymph Nodes - pathology Lymph Nodes - surgery Mammary gland diseases Medical prognosis Medical sciences Medicine Medicine & Public Health Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Neoplasm Grading Neoplasm Recurrence, Local - metabolism Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - therapy Oncology Original Paper Pharmacology. Drug treatments Prognosis Survival Rate Tumors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!